BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, February 9, 2026
See today's BioWorld
Home
» India's new drug price databank met with mixed reviews
To read the full story,
subscribe
or
sign in
.
India's new drug price databank met with mixed reviews
June 30, 2015
By
T.V. Padma
NEW DELHI – India has launched a pharmaceutical price databank to be managed and operated by its drug pricing regulator, the National Pharmaceutical Pricing Authority (NPPA), to help consumers make informed product formulation and rate choices.
BioWorld